The Open Biochemistry Journal




ISSN: 1874-091X ― Volume 13, 2019

Nitrergic Response TO Cyclophosphamide Treatment in Blood and Bone Marrow



G.A Kevorkian*, N.Kh Alchujyan, N.H Movsesyan, H.L Hayrapetyan, A.G Guevorkian, R.M Ohanyan , S.S Dagbashyan

Abstract

Daily intraperitoneal injection of cyclophosphamide (CPA) (50 mg∙kg-1 of body weight) for 5 days resulted in reduced levels of marrow and blood cellularity, which was most pronounced in 18 days post-treatment (pt). On day 18 after CPA treatment the enhancedlevels of nitric oxide (NO) precursors and metabolites (L-arginine, L-citrulline, reactive nitrogen species (RNS)) of marrow and blood cells (platelet, neutrophil, lymphocyte and monocyte) resulted from up-regulation of Ca(II)/calmodulin(CaM)-independent “inducible” NO synthase (iNOS), with a lessercontribution of Ca(II)/CaM-dependent “constitutive” cNOS isoforms to systemic NO.Biphasic response to CPA of marrow nitrergic system, i.e. both iNOS and cNOS showed significantly depressed activities, as well as diminished levels of NO metabolites on day 9 pt, suggested that signals in addition to NO might be involved in CPA-induced inhibition of hematopoesis, while a gradual increase of neutrophil and platelet NOS activity appeared to be contributed to a CPA-induced development of granulopenia, thrombocytopenia and hemorrhage.

Key words: Cyclophosphamide, arginine, blood formed elements, citrulline, nitric oxide synthase, marrow, rat.


Article Information


Identifiers and Pagination:

Year: 2008
Volume: 2
First Page: 81
Last Page: 90
Publisher Id: TOBIOCJ-2-81
DOI: 10.2174/1874091X00802010081

Article History:

Received Date: 7/4/2008
Revision Received Date: 22/4/2008
Acceptance Date: 13/5/2008
Electronic publication date: 3/6/2008
Collection year: 2008

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 1834
Abstract HTML Views: 621
PDF Downloads: 215
Total Views/Downloads: 2670

Unique Statistics:

Full-Text HTML Views: 540
Abstract HTML Views: 373
PDF Downloads: 153
Total Views/Downloads: 1066
Geographical View

© Kevorkian et al.; Licensee Bentham Open

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.


* Address correspondence to these authors at the H. Buniatian Institute of Biochemistry NAS RA, 5/1 P.Sevak St., 0014, Yerevan, Republic of Armenia; E-mail: kevork_neurochem@mail.ru


Endorsements



"We have always had a fruitful cooperation and long-term experience of publishing with Bentham Open."

"A number of our original papers have appeared in its different journals, as the Bentham Open Publishers provides sufficient research in the field of science and technologies (belonging to the pharmaceutical, biotechnology, biomedical industries etc). The staff of the Bentham Open always treat our papers very seriously and gently during the rutile paper reviewing process, so far we always felt their kindness and highly cooperative support. Today, Bentham Open is providing a great support to science and research, giving opportunities of high standard publishing as well as promoting and enhancing selected papers around the world through communication and exchange of global scientific education."


Kholmirzo T. Kholmurodov
Leading Scientist
FLNP (Frank Laboratory of Neutron Physics) JINR (Joint Institute of Nuclear Research) Moscow region, Russia


Browse Contents



Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open